Biogen Inc. (BIIB) Earns Market Perform Rating from BMO Capital Markets

Biogen Inc. (BIIB) Earns Market Perform Rating from BMO Capital Markets


's stock had its "market perform" rating reaffirmed by stock analysts at BMO Capital Markets in a research report issued on Sunday. They presently have a $287.00 target price on the biotechnology company's stock.



from Biotech News